fying potential pregnancy-related complica-
tions as early as possible; 
(iv) barriers that prevent maternal 
health care providers from providing tele-
health services across States and rec-
ommendations from the Centers for Medi-
care and Medicaid Services for addressing 
such barriers in State Medicaid programs; 
(v) the use of consumer digital tool 
such as mobile phone applications, patient 
portals, and wearable technologies to im-
prove maternal health outcomes; 
(vi) barriers that prevent consumers 
from accessing telehealth services or other 
digital technologies to improve maternal 
health outcomes, including a lack of access 
to reliable, high-speed internet or lack of 
access to electronic devices needed to use 
such services and technologies; and 
(vii) any other related issues as deter-
mined by the Secretary. 
(f) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this section, 
$6,000,000 for each of fiscal years 2021 through 2025. 
VerDate Sep 11 2014 
23:13 Mar 13, 2020
Jkt 099200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H6138.IH
H6138
pamtmann on DSKBC07HB2PROD with BILLS
(g) ELIGIBLE ENTITY DEFINED.—In this section, 
the term ‘‘eligible entity’’ is an entity that is described 
in section 51a.3(a) of title 42, Code of Federal Regula-
tions, including domestic faith-based and community- 
based organizations. 
SEC. 5. REPORT ON THE USE OF TECHNOLOGY TO REDUCE 
MATERNAL MORTALITY AND SEVERE MATER-
NAL MORBIDITY AND TO CLOSE RACIAL AND 
ETHNIC DISPARITIES IN OUTCOMES. 
(a) IN GENERAL.—Not later than 60 days after the 
date of enactment of this Act, the Secretary of Health and 
Human Services shall seek to enter an agreement with the 
National Academies of Sciences, Engineering, and Medi-
cine (referred to in this Act as the ‘‘National Academies’’) 
under which the National Academies shall conduct a study 
on the use of technology to reduce preventable maternal 
mortality and severe maternal morbidity, and close racial 
and ethnic disparities in maternal health outcomes in the 
United States. The study shall assess current and future 
uses of artificial intelligence in maternity care, including 
issues such as— 
(1) the extent to which artificial intelligence 
technologies are currently being used in maternal 
health care; 
VerDate Sep 11 2014 
23:13 Mar 13, 2020
Jkt 099200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H6138.IH
H6138
pamtmann on DSKBC07HB2PROD with BILLS
(2) the extent to which artificial intelligence 
technologies have exacerbated racial or ethnic biases 
in maternal health care; 
(3) recommendations for reducing racial or eth-
nic biases in artificial intelligence technologies used 
in maternal health care; 
(4) recommendations for potential applications 
of artificial intelligence technologies that could im-
prove maternal health outcomes, particularly for mi-
nority women; and 
(5) recommendations for privacy and security 
safeguards that should implemented in the develop-
ment of artificial intelligence technologies in mater-
nal health care. 
(b) REPORT.—As a condition of any agreement under 
subsection (a), the Administrator shall require that the 
National Academies transmit to Congress a report on the 
results of the study under subsection (a) not later than 
24 months after the date of enactment of this Act. 
SEC. 6. DEFINITIONS. 
In this section: 
(1) MATERNAL MORTALITY.—The term ‘‘mater-
nal mortality’’ means a death occurring during or 
within a 1-year period after pregnancy caused by 
pregnancy or childbirth complications. 
VerDate Sep 11 2014 
20:07 Mar 24, 2020
Jkt 099200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H6138.IH
H6138
pamtmann on DSKBC07HB2PROD with BILLS
(2) SEVERE MATERNAL MORTALITY.—The term 
‘‘severe maternal morbidity’’ means an unexpected 
outcome caused by labor and delivery of a woman 
that results in significant short-term or long-term 
consequences to the health of the woman. 
Æ 
VerDate Sep 11 2014 
20:07 Mar 24, 2020
Jkt 099200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6301
E:\BILLS\H6138.IH
H6138
pamtmann on DSKBC07HB2PROD with BILLS